Hannah H. Chang


Hannah Chang is a managing director at Wu Capital. She focuses on early-stage biopharmaceutical investments out of the firm’s San Francisco office which she leads. Representative investments include Semma Therapeutics (acquired by Vertex Pharmaceuticals), Akouos (Nasdaq: AKUS), PACT Pharma and Gemini Therapeutics.

She was previously an investme...

Roles at Korro Bio

  • Director

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.